Artiva Biotherapeutics, Inc. (ARTV)
4.68
+0.15
(+3.31%)
USD |
NASDAQ |
Feb 20, 16:00
4.69
+0.01
(+0.21%)
After-Hours: 20:00
Artiva Biotherapeutics Total Assets (Quarterly) : 148.86M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Rocket Pharmaceuticals, Inc. | 368.03M |
| Merck & Co., Inc. | -- |
| Regeneron Pharmaceuticals, Inc. | 40.56B |
| Innoviva, Inc. | 1.429B |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.64M |
| Shareholders Equity (Quarterly) | 129.22M |
| Debt to Equity Ratio | 0.0905 |
| Current Ratio | 11.65 |
| Net Debt Paydown Yield | 1.16% |